-
Alphatec revenue grows 27% in Q1
Spine technology company Alphatec saw 27% revenue growth in the first quarter of 2024, reaching $138 million. -
6 medtech notes: Zimmer Biomet, Orthofix and more
From financial updates to new product developments, here are the key headlines from spine devicemakers since May 1. -
Smaller version of SI-Bone spine implant launched
A smaller version of SI-Bone's iFuse bedrock granite implant system was launched, and the first cases with it were completed, the medtech company said May 7. -
Globus Medical's Q1 sales soar 119.3%: 6 notes
Globus Medical saw a 119.3% year-over-year increase in first quarter sales, according to financial results posted May 7. -
Orthofix sees $36M net loss in Q1
Orthofix saw sales growth but a net loss in the first quarter of 2024, according to financial results posted May 7. -
ZygoFix earns FDA nod for lumbar fixation system
ZygoFix earned FDA clearance for its zLock device, the company said in a May 6 LinkedIn post. -
5 things to know about Stryker's orthopedics and spine president
Spencer Stiles is group president of orthopedics and spine at Stryker. -
Stryker vs. Zimmer Biomet vs. Johnson and Johnson: How they compare in Q1 2024
Stryker, Johnson & Johnson and Zimmer Biomet posted their first-quarter financial results for 2024 and data on their orthopedic sales. -
OrthoPediatrics earns breakthrough designation for new scoliosis rod system
OrthoPediatrics earned the FDA's breakthrough designation for the eLLi growing rod system for scoliosis, the devicemaker said May 2. -
Zimmer Biomet sees robotic progress, executive exit: 5 Q1 earnings call notes
Zimmer Biomet is kicking off the year strong with first quarter sales growth and progress with its newer technologies, according to a May 2 earnings call. -
Zimmer Biomet sales rise 3.2% in Q1
Zimmer Biomet saw $1.89 billion in net sales in the first quarter of 2024, according to its 2024 financial report, published May 2. -
How Orthofix paid its current, former executives
Orthofix's new CEO Massimo Calafiore started his new role Jan. 8 with an annual base salary of $825,000, according to the company's April 29 proxy statement. -
How much 4 Globus Medical execs were paid since 2021
Globus Medical CEO Daniel Scavilla's salary rose to $4.6 million in 2023, according to the company's April 26 Securities and Exchange Commission proxy filing. -
Spinal Simplicity's SI joint system gets FDA clearance
Spinal Simpicity's Patriot-SI posterior implant system for sacroiliac joint fusion earned FDA 510(k) clearance. -
Ousted Orthofix execs seek arbitration
Three former Orthofix executives who were fired in 2023 filed arbitration claims alleging wrongful termination, the medtech company said in its April 29 proxy statement. -
Stryker's Mako Spine now projected for Q4 launch: 5 earnings call notes
Stryker is making strides in its spine robot launch and saw strong spine business growth in the first quarter of 2024, leaders said in an April 30 earnings call. -
9 medtech notes: Medtronic, Stryker and more
From layoffs to quarterly updates, here are nine updates from spine and orthopedic medtech companies since April 24. -
Stryker sees $5.2B in Q1 sales
Stryker saw a 9.7% year-over-year increase in sales during the first quarter of 2024, according to financial results posted April 30. -
Aurora Spine's revenue grows in Q4
Aurora Spine saw fourth quarter growth in 2023, according to financial results posted April 29. -
Spineart, SpinEM Robotics launch strategic partnership
Robotic spinal surgery navigation company SpinEM Robotics has closed a series A2 funding round, securing an $11 million investment from spine surgery innovator Spineart.
Page 1 of 192